Just like bad medicine…Trump tariff pricks again; India not seen badly hit by US’ latest salvo

Just like bad medicine…Trump tariff pricks again; India not seen badly hit by US’ latest salvo

US President Donald Trump’s Friday announcement of a 100% tariff on pharmaceutical products may not affect Indian pharma exports as the measure currently targets only “patented and branded products,” while India predominantly ships generic drugs to the US, experts said. “Because the 100% tariff is targeted at branded/patented drugs, most Indian generic exports would not…

Read More
Trump’s 100% tariff on pharma will not impact generic makers, says Indian Pharma Alliance

Trump’s 100% tariff on pharma will not impact generic makers, says Indian Pharma Alliance

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump’s move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines. Reacting to the development, IPA Secretary General Sudarshan Jain said in a statement, “It is not applicable to generics medicines.”…

Read More